Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2024)
Top medical stocks in 2024 ranked by overall Due Diligence Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...

Overview Due Diligence Score Price Valuation Financials Forecast Earnings & Revenue

Ticker	Company	Market Cap	Revenue	EBITDA	Earnings	EPS	Revenue Growth Y/Y	Revenue Growth 5Y	Earnings Growth Y/Y	Earnings Growth 5Y	Earnings Date
HOLX	HOLOGIC INC	$17.10B	$4.03B	$1.30B	$789.50M	$3.35	-0.00%	3.66%	81.08%	N/A	2025-01-30
RMD	RESMED INC	$35.44B	$4.81B	$1.62B	$1.11B	$7.56	9.88%	12.24%	22.53%	20.87%	2025-01-22
UTMD	UTAH MEDICAL PRODUCTS INC	$216.52M	$44.08M	$21.36M	$15.26M	$4.27	-14.35%	-0.34%	-8.37%	2.96%	2025-01-28
BDX	BECTON DICKINSON & CO	$63.61B	$20.18B	$4.82B	$1.71B	$5.88	4.16%	3.14%	18.31%	7.96%	2025-01-30
LMAT	LEMAITRE VASCULAR INC	$2.27B	$213.03M	$63.80M	$41.32M	$1.86	14.81%	13.03%	51.22%	13.67%
ISRG	INTUITIVE SURGICAL INC	$196.04B	$7.87B	$2.86B	$2.24B	$6.33	14.83%	13.12%	46.53%	10.70%	2025-01-21
MMSI	MERIT MEDICAL SYSTEMS INC	$6.08B	$1.33B	$285.97M	$120.04M	$2.07	8.12%	6.45%	18.97%	44.37%
ATR	APTARGROUP INC	$11.39B	$3.57B	$738.48M	$335.95M	$5.08	3.73%	4.46%	18.14%	6.54%	2025-02-06
ALC	ALCON INC	$42.91B	$9.76B	$2.49B	$1.16B	$2.35	5.25%	5.73%	161.11%	N/A
WST	WEST PHARMACEUTICAL SERVICES INC	$23.36B	$2.88B	$760.40M	$499.60M	$6.81	-1.71%	9.93%	-9.32%	16.97%
HAE	HAEMONETICS CORP	$4.08B	$1.36B	$276.90M	$123.81M	$2.43	9.84%	6.63%	-3.95%	12.64%	2025-02-06
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$11.25M	$94.25M	$12.57M	$9.28M	$0.39	-2.53%	N/A	44.44%	N/A
NYXH	NYXOAH SA	$263.08M	$5.46M	-$46.72M	-$56.97M	-$1.85	38.55%	N/A	N/A	N/A	2025-01-07
STAA	STAAR SURGICAL CO	$1.25B	$341.22M	$33.76M	$21.78M	$0.44	10.01%	19.08%	2.33%	17.08%
TFX	TELEFLEX INC	$8.58B	$3.03B	$619.35M	$237.44M	$5.06	2.27%	3.43%	-41.09%	-12.06%
ATRC	ATRICURE INC	$1.67B	$447.57M	-$12.95M	-$38.92M	-$0.83	17.56%	15.01%	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$291.66M	$224.26M	$25.00M	$11.37M	$0.15	-50.46%	7.64%	-77.27%	-17.40%
COO	COOPER COMPANIES INC	$19.70B	$3.90B	$1.11B	$392.30M	$1.97	8.41%	7.98%	32.21%	-3.55%
WRBY	WARBY PARKER INC	$2.86B	$742.53M	$5.72M	-$32.56M	-$0.27	13.47%	N/A	N/A	N/A
INFU	INFUSYSTEM HOLDINGS INC	$189.88M	$132.78M	$17.66M	$1.48M	$0.06	8.09%	11.52%	100.00%	24.57%
XRAY	DENTSPLY SIRONA INC	$3.79B	$3.90B	$63.00M	-$413.00M	-$2.07	-0.91%	-0.39%	N/A	N/A
NEPH	NEPHROS INC	$16.99M	$13.55M	-$774.00k	-$929.00k	-$0.09	0.03%	9.05%	N/A	N/A
EMBC	EMBECTA CORP	$1.11B	$1.12B	$199.70M	$69.70M	$1.20	0.48%	N/A	36.36%	N/A	2025-02-07
LUCY	INNOVATIVE EYEWEAR INC	$16.24M	$1.56M	-$7.91M	-$8.03M	-$9.66	158.62%	N/A	N/A	N/A
HBIO	HARVARD BIOSCIENCE INC	$98.57M	$97.73M	-$3.03M	-$14.24M	-$0.33	-13.15%	-3.87%	N/A	N/A
POAI	PREDICTIVE ONCOLOGY INC	$5.35M	$1.38M	-$13.69M	-$13.97M	-$3.05	-22.09%	0.05%	N/A	N/A
SMTI	SANARA MEDTECH INC	$320.28M	$78.06M	-$1.42M	-$8.36M	-$0.99	24.66%	55.95%	N/A	N/A
PDEX	PRO DEX INC	$175.25M	$56.80M	$8.54M	$5.21M	$1.55	21.01%	15.61%	4.73%	10.06%	2025-02-06
EKSO	EKSO BIONICS HOLDINGS INC	$14.91M	$17.68M	-$8.97M	-$11.13M	-$0.65	4.12%	5.56%	N/A	N/A
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$115.52M	$20.13M	$3.45M	$2.91M	$0.02	0.75%	N/A	-19.05%	N/A
PLSE	PULSE BIOSCIENCES INC	$1.21B	$0.00	-$46.59M	-$46.13M	-$0.81	N/A	N/A	N/A	N/A
BLFS	BIOLIFE SOLUTIONS INC	$1.22B	$123.36M	-$35.11M	-$46.03M	-$0.72	-8.47%	38.13%	N/A	N/A
FEMY	FEMASYS INC	$25.65M	$1.26M	-$15.89M	-$18.10M	-$0.81	15.33%	N/A	N/A	N/A
BAX	BAXTER INTERNATIONAL INC	$16.24B	$13.99B	$1.81B	$108.00M	$0.21	3.13%	4.63%	-95.91%	-39.45%	2025-02-06
KRMD	KORU MEDICAL SYSTEMS INC	$174.18M	$31.99M	-$5.62M	-$11.97M	-$0.25	11.57%	8.57%	N/A	N/A
NXGL	NEXGEL INC	$23.70M	$6.73M	-$2.79M	-$3.53M	-$0.59	90.49%	46.35%	N/A	N/A
STVN	STEVANATO GROUP SPA	$6.20B	$1.18B	$276.66M	$123.33M	$0.46	8.13%	N/A	-19.80%	N/A
BLCO	BAUSCH & LOMB CORP	$7.07B	$4.68B	$551.00M	-$368.00M	-$1.05	18.01%	N/A	N/A	N/A
AVGR	AVINGER INC	$2.61M	$7.26M	-$17.16M	-$17.35M	-$8.96	-6.26%	-3.32%	N/A	N/A
BNGO	BIONANO GENOMICS INC	$23.87M	$33.33M	-$115.33M	-$135.78M	-$2.32	-0.82%	24.03%	N/A	N/A
AZTA	AZENTA INC	$2.51B	$656.32M	-$76.58M	-$164.17M	-$3.09	-1.32%	-3.41%	N/A	N/A	2025-02-05
POCI	PRECISION OPTICS CORPORATION INC	$32.32M	$18.98M	-$3.36M	-$3.80M	-$0.63	-6.41%	19.59%	N/A	N/A
RVP	RETRACTABLE TECHNOLOGIES INC	$18.56M	$38.27M	$178.61k	-$15.96M	-$0.54	-8.86%	0.44%	N/A	N/A
RGEN	REPLIGEN CORP	$8.36B	$633.51M	$118.65M	-$8.10M	-$0.14	-2.91%	20.18%	N/A	N/A
MLSS	MILESTONE SCIENTIFIC INC	$68.93M	$8.88M	-$4.63M	-$4.62M	-$0.07	-9.49%	-2.04%	N/A	N/A
ICUI	ICU MEDICAL INC	$3.81B	$2.34B	$230.85M	-$111.01M	-$4.57	4.04%	12.63%	N/A	N/A
OMIC	SINGULAR GENOMICS SYSTEMS INC	$50.29M	$2.67M	-$78.33M	-$86.32M	-$34.79	2.74%	N/A	N/A	N/A
ZTEK	ZENTEK LTD	$113.43M	$28.31k	-$7.06M	-$7.73M	-$0.09	7.35%	N/A	N/A	N/A
MBOT	MICROBOT MEDICAL INC	$16.56M	$0.00	-$11.11M	-$11.21M	-$0.80	N/A	N/A	N/A	N/A
ANGO	ANGIODYNAMICS INC	$284.44M	$292.73M	-$210.90M	-$243.03M	-$6.03	-12.85%	1.42%	N/A	N/A	2025-01-03
NVST	ENVISTA HOLDINGS CORP	$3.42B	$2.50B	-$1.13B	-$1.34B	-$7.81	-3.04%	-2.15%	N/A	N/A	2025-02-05
STSS	SHARPS TECHNOLOGY INC	$3.61M	$0.00	-$7.15M	-$7.87M	-$8.31	N/A	N/A	N/A	N/A
AKYA	AKOYA BIOSCIENCES INC	$105.07M	$86.82M	-$39.79M	-$57.97M	-$1.16	-4.98%	N/A	N/A	N/A
STXS	STEREOTAXIS INC	$187.25M	$25.14M	-$20.81M	-$22.89M	-$0.27	-14.79%	-3.00%	N/A	N/A
GCTK	GLUCOTRACK INC	$1.47M	$0.00	-$13.08M	-$14.92M	-$2.83	N/A	-100.00%	N/A	N/A

Medical Stocks FAQ

What are the best medical stocks to buy right now in Dec 2024?

According to Due Diligence Score, the 3 best medical stocks to buy right now are:

1. Hologic (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) is the top medical stock with a Due Diligence Score of 55, which is 27 points higher than the medical industry average of 28. It passed 17 out of 33 due diligence checks and has strong fundamentals. Hologic has seen its stock return 9.01% over the past year, underperforming other medical stocks by -9 percentage points.

Hologic has an average 1 year price target of $89.40, an upside of 18.66% from Hologic's current stock price of $75.34.

Hologic stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Hologic, 20% have issued a Strong Buy rating, 40% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Resmed (NYSE:RMD)

Resmed (NYSE:RMD) is the second best medical stock with a Due Diligence Score of 54, which is 26 points higher than the medical industry average of 28. It passed 20 out of 38 due diligence checks and has strong fundamentals. Resmed has seen its stock return 47.2% over the past year, overperforming other medical stocks by 29 percentage points.

Resmed has an average 1 year price target of $244.50, an upside of 1.28% from Resmed's current stock price of $241.41.

Resmed stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Resmed, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 33.33% have issued a hold, while 16.67% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Lemaitre Vascular (NASDAQ:LMAT)

Lemaitre Vascular (NASDAQ:LMAT) is the third best medical stock with a Due Diligence Score of 48, which is 20 points higher than the medical industry average of 28. It passed 18 out of 38 due diligence checks and has strong fundamentals. Lemaitre Vascular has seen its stock return 86.43% over the past year, overperforming other medical stocks by 69 percentage points.

Lemaitre Vascular has an average 1 year price target of $95.50, a downside of -5.56% from Lemaitre Vascular's current stock price of $101.12.

Lemaitre Vascular stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Lemaitre Vascular, 0% have issued a Strong Buy rating, 75% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 9 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 3.25%, which is 2 percentage points higher than the medical industry average of 1.36%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -30% indicates that its dividend yield might not be sustainable for the long-term.

2. Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) has an annual dividend yield of 2.36%, which is 1 percentage points higher than the medical industry average of 1.36%. Baxter International's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of 552.4% indicates that its dividend yield might not be sustainable for the long-term.

3. Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) has an annual dividend yield of 1.88%, which is 1 percentage points higher than the medical industry average of 1.36%. Utah Medical Products's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Utah Medical Products's dividend has shown consistent growth over the last 10 years.

Utah Medical Products's dividend payout ratio of 28.1% indicates that its dividend yield is sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 0.35% in the last day, and down -2.03% over the last week.

We couldn't find a catalyst for why medical stocks are up.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 71, which is 54 points higher than the medical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -21.73% in the past year. It has underperformed other stocks in the medical industry by -40 percentage points.

2. Hologic (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Hologic has a valuation score of 71, which is 54 points higher than the medical industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Hologic's stock has gained 9.01% in the past year. It has underperformed other stocks in the medical industry by -9 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 57, which is 40 points higher than the medical industry average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has gained 9.13% in the past year. It has underperformed other stocks in the medical industry by -9 percentage points.

Are medical stocks a good buy now?

45.95% of medical stocks rated by analysts are a buy right now. On average, analysts expect medical stocks to rise by 14.39% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 38.62x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.